PREDICTIVE GENETIC TESTING OF FEMALE CANCER
We work alongside women for the prevention of female cancers.
We offer genetic tests for the prevention of breast, ovarian and endometrial cancers, ensuring high quality standards at every stage of the production process and in the interpretation of data.
Why take the tests
It is estimated that, in the female population, between 5 and 10% of breast, ovarian and uterine cancers are due to a genetic predisposition.
Who the tests are for
These genetic tests are aimed at doctors and their patients to confirm a clinical suspicion or to search for any subjects at risk, in case of familiarity.
What the tests detect
The tests detect the presence of pathogenetic variations in the genes investigated by NGS sequencing.
Reliability
The tests have a sensitivity and specificity higher than 99%, each clinically significant variant is validated with a second method, in compliance with the most stringent guidelines of medical genetics.
